Nomax Inc FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection NAI · Feb 25, 2026
  • Last warning letter 2016
Inspections 10 0 OAI
Recalls 8 0 Class I (0%)
Warning letters 1 Latest Dec 15, 2016
510(k) clearances 1 Latest May 12, 1993

Nomax Inc has 8 FDA recalls, 10 inspections, 1 510(k) clearance and 1 compliance action on record. FDA has issued 1 warning letter to Nomax Inc, the most recent on Dec 15, 2016.

What these totals cover: FDA records filed under the name "Nomax Inc" and its spelling variant "Nomax".

Latest recall
D-0465-2024 · Class II · Apr 19, 2024
Latest inspection
Feb 25, 2026 · NAI
Latest 510(k)
May 12, 1993

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls8Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances1Nov 15, 2026File dated Nov 9, 2026Current
Inspections10Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Nomax Inc's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Nomax Inc: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2020: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2022: 2 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 1 inspection (0 OAI), 0 warning letters, 4 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202610000
202500000
202410040
202300000
202220000
202100010
202000000
201900000
201810000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Nomax Inc as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Nomax Inc yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Nomax Inc FDA Warning Letters

1 warning letter on Dec 15, 2016.

IssuedSubjectIssuing officeClose-out letter
Dec 15, 2016 · Record page

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

8 recall records from Mar 24, 2015 to Apr 19, 2024.

NumberClassProductDate
D-0465-2024Class IIFUL-GLO, Fluorescein Sodium Ophthalmic Strips USP 1 mg, 100 sterile strips per carton, Manufactured…Apr 19, 2024
D-0462-2024Class IIGloStrips, Fluorescein Sodium Ophthalmic Strips USP (0.6 mg Fluorescein), Rx Only, a) 100 strips per…Apr 19, 2024
D-0464-2024Class IIFUL-GLO, Fluorescein Sodium Sterile Ophthalmic Strips USP (0.6 mg Fluorescein), 300 sterile strips…Apr 19, 2024
D-0463-2024Class IIGloStrips, Fluorescein Sodium Ophthalmic Strips USP (1.0 mg Fluorescein), Rx Only, 100 Sterile…Apr 19, 2024
D-0387-2021Class IIIDry Eye Test, Fluorescein Sodium, Ophthalmic Strips USP (0.12mg Fluorescein Sodium), 100 Sterile…Apr 13, 2021
D-0962-2015Class IIIRose Bengal GloStrips (rose bengal) Ophthalmic Strips USP, 1.3 mg per strip, individually wrapped…Mar 24, 2015
D-0963-2015Class IIIFluorescein Sodium Ophthalmic Strips USP, 1.0 mg per strip, labeled as 1) FUL-GLO, individually…Mar 24, 2015
D-0961-2015Class IIIFluorescein Sodium Ophthalmic Strips USP, 0.6 mg per strip, labeled as 1) Fluorescein GloStrips…Mar 24, 2015

Recent FDA inspections

10 inspections from Jul 26, 2010 to Feb 25, 2026.

DateSiteProductClassificationFEI
Feb 25, 2026Saint Louis, MOFood/CosmeticsNo Action Indicated (NAI)1937310
Feb 16, 2024Saint Louis, MOFood/CosmeticsNo Action Indicated (NAI)1937310
Dec 2, 2022Saint Louis, MODrugsVoluntary Action Indicated (VAI)1937310
Jun 24, 2022Saint Louis, MOFood/CosmeticsNo Action Indicated (NAI)1937310
Feb 1, 2018Saint Louis, MODevicesNo Action Indicated (NAI)1937310
Oct 27, 2016Saint Louis, MODevicesNo Action Indicated (NAI)1937310
Sep 17, 2014Saint Louis, MODevicesVoluntary Action Indicated (VAI)1937310
Jan 31, 2012Saint Louis, MODrugsVoluntary Action Indicated (VAI)1937310
Mar 25, 2011Saint Louis, MODrugsVoluntary Action Indicated (VAI)1937310
Jul 26, 2010Saint Louis, MODrugsNo Action Indicated (NAI)1937310
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Nomax Inc: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Dec 15, 2016.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 1937310Saint Louis, MO10Feb 25, 2026

Recent 510(k) clearances

1 510(k) clearance on May 12, 1993.

K-NumberDeviceDate
K923458CONTACT LENS CASEMay 12, 1993

Nomax Inc and the FDA: common questions

Has Nomax Inc received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Nomax Inc. The most recent is dated Dec 15, 2016.

Has Nomax Inc received an FDA Form 483?

FDA has not published a Form 483 for "Nomax Inc" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Nomax Inc?

The most recent FDA inspection on file ended Feb 25, 2026 at Saint Louis, MO and was classified NAI. FDA has 10 inspections of Nomax Inc on file.

Has Nomax Inc had an FDA recall?

Yes. Nomax Inc has 8 FDA recalls on record. The most recent started Apr 19, 2024.

Need more than this page shows? Ask about Nomax Inc in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.